ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

Researchers Plan to Extend Phase IIa Asonep Trial

August 29, 2014

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

October 13, 1989

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995